Prevalence of hepatitis C in patients with chronic kidney disease at a tertiary care hospital in north India: a retrospective analysis

Amrit Dhar; Vijant S. Chandail; Viney Sambyal; Vinu Jamwal

doi:10.18203/2320-6012.ijrms20192498

Authors

Amrit Dhar Department of Internal Medicine, Government Medical College Jammu, Jammu and Kashmir, India
Vijant S. Chandail Department of Internal Medicine, Government Medical College Jammu, Jammu and Kashmir, India
Viney Sambyal Department of Internal Medicine, Government Medical College Jammu, Jammu and Kashmir, India
Vinu Jamwal Department of Internal Medicine, ASCOMS, Jammu, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20192498

Keywords:

Chronic kidney disease, Haemodialysis, Hepatitis C, Prevalence

Abstract

Background: Hepatitis C and chronic kidney disease (CKD) both present an unsolved public health problem Hepatitis C virus (HCV) is easily transmitted in haemodialysis units and by kidney transplantation. HCV leads to increased mortality and morbidity due to cirrhosis and hepatocellular carcinoma, while accelerating the progression of CKD. The aim of the study was to describe the demographic, clinical/biochemical profile and prevalence of patients with CKD who have HCV infection.

Methods: This was a retrospective analysis of patients with CKD who presented to out/in patient department of medicine in a tertiary care center in Jammu from a period of Feb 2016 to Nov 2018. Detailed clinical history along with previous lab reports were noted and tests for HCV infection were conducted in all patients. Diagnosis of HCV was made via HCV RNA(RT PCR) and positive Anti HCV IgG serology.

Results: Total 67 patients were included with median age of 54 years (range 43-72 years) with majority 76.1% being males, and 71.6% within 41-60 years age group. 31.4% were HCV positive out of which 81% were males. 7 patients were found to have co-infection with HIV and HBsAg. Genotype 1 (72%) was found to be more common than Genotype 3. Ultrasonography and Upper GI endoscopy showcased 57% with dilated spleenoportal axis and oesophageal varices respectively.

Conclusions: Prevalence of HCV infection in CKD patients is high with genotype 1 being commonest. False negative Anti HCV antibody is common hence screening with HCV RNA is recommended. Strict universal precautions should be employed in hospitals and dialysis units to prevent transmission.

Metrics

Metrics Loading ...

References

Bhattacharya PK, Roy A. Management of hepatitis C in the Indian context: an update. J Liver. 2015;4(187):2167-0889.

Ladino M, Pedraz F, Roth D. Hepatitis C Virus Infection in Chronic Kidney Disease. J Am Soc Nephrol. 2016;27(8):2238-46.

Ozer Etik D, Ocal S, Boyacioglu AS. Hepatitis C infection in hemodialysis patients: A review. World J Hepatol. 2015;7(6):885-95.

Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol. 2008;49(4):613-24.

Fissel RB, Bragg-Gresaham Jl, Woods JD. Patterns of hepatitis C: prevalence and seroconversion in hemodialysis units from three continents: DOPPS. Kidney Int. 2004;65(6):2335-42.

Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial. 2007;20(5):416-22.

Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol. 2008;69(3):149-60.

Berenguer Marina. Treatment of chronic hepatitis C in hemodialysis patients. Hepatol. 2008;48(5):1690-9.

Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18(11-12):1071-81.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1-150.

Jaiswal SP, Chitnis DS, Naik G. Prevalence of anti-HCV antibodies in central India. Indian J Med Res. 1996;104:177-81.

Gosavi MS, Shah SK, Shah SR, Pal RB, Saldanha JA, Banker DD. Prevalence of hepatitis C virus (HCV) infection in Mumbai. Indian J Med Sci. 1997;51(10):378-85.

Chandra M, Khaja MN, Hussain MM. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirol. 2004;47(6):374-6.

Reddy AK, Murthy KV, Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol. 2005;23(2):106-10.

Medhi S, Potukuchi SK, Polipalli SK. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Clin Biochem. 2008;41(7-8):447-52.

Jasuja S, Gupta AK, Choudhry R. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2009;19(2):62-7.

Shafi ST, Hassan MZ, Saleem M, Anjum R, Abdullah W, Shafi T. Frequency of Hepatitis C in hospitalized patients with chronic kidney disease. Pak J Med Sci. 2017;33(1):18-21.

Fabrizi F, Marcelli D, Bacchini G, Guarnori I, Erba G, Locatelli F. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant. 1994;9(7):780-4.

Arora A, Bansal N, Sharma P, Singla V, Gupta V, Tyagi P, et al. Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India. J Clin Exp Hepatol. 2016;6(1):21-5.

Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El-Kafrawy S, Esmat G, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006;55(8):1183-7

Gomez-Marcos MA, Recio-Rodriguez JI, Gomez-Sanchez L, Agudo- Conde C, Rodriguez-Sanchez E, Maderulo-Fernandez M, et al. Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-Diabetes study. Cardiovasc Diabetol. 2015;14:132.

Idrees MK, Batool S, Ahmed E. Hepatitis B virus among maintainence haemodialysis patients: a report from Karachi, Pakistan. Age (years). 2011;34:12-68.

Scherzer R, Shlipak MG. Risk factors: Individual assessment of CKD risk in HIV-positive patients. Nat Rev Nephrol. 2015;11(7):392-3.

Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, et al. Canadian Co-infection Cohort Investigators: Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). AIDS. 2014;28(13):1957-65.

Prati D, Taioli E, Zanella A. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1-10.

Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y, Sakhuja V. Treatment of chronic hepatitis C in end stage renal disease: experience at a tertiary care centre. Trop Gastroenterol. 2012;33(3):189-92.

Seth AK, Chandra A, Puri P, Kaur J. Genotype 1 hepatitis C virus infection predominates among patients with chronic kidney failure and renal allograft recipients in India. Indian J Gastroenterol. 2009;28(4):159-60.

Weinstein T, Kaspa TR, Chagnac A, Korzets A, Ori Y, Zevin D, et al. Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J. 2001;3(3):174-7.

Fabirizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, et al. Serologic survey for control of hepatitis C in hemodialysis patients: Third-generation assays and analysis of costs. Nephrol Dial Transplant. 1997;12(2):298-303.

Liu CH, Kao JH. Treatment of hepatitis C virus infection in patients with end-stage renal disease. J Gastroenterol Hepatol. 2011;26(2):228-39.

Fabrizi F, Poordad FF, Martin P. Diagnostic workup of hepatitis C and the patient on maintenance dialysis. Int J Artif Organs. 2001;24(12):325:98.

Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long term study of hepatitis C virus replication in non A, non B hepatitis. N Engl J Med. 1991;325(2):98-104.

Cotler SJ, Diaz G, Gundlapalli S. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol. 2002;35(2):191-5.

Lakshmi V, Reddy AK, Dakshinamurty KV. Evaluation of commercially available third-generation anti-hepatitis C virus enzyme-linked immunosorbent assay in patients on haemodialysis. Ind J Med Microbiol. 2007;25(2):140-2.

Rostami Z, Nourbala MH, Alavian SM, Bieraghdar F, Jahani Y, Einollahi B. The impact of hepatitis C virus infection on kidney transplantation outcome: a systematic review of 18 observational studies. Hepat Mon. 2011;11(4):247-54.

Park H, Adeyemi A, Henry L, Stepanova M, Younossi Z. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection. J Viral Hepat. 2015;22(11):897-905.

Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AE, et al. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients. Nephron Clin Pract. 2008;108(2):135-40.